Corbus Pharmaceuticals назначила нового главного медицинского директора

Corbus Pharmaceuticals Holdings, Inc. (CRBP), a company focused on oncology and obesity, said on Monday that it has appointed Leonardo Viana Nicacio as Chief Medical Officer. Prior to joining Corbus, Nicacio was the CMO of Protara Therapeutics Inc.(TARA), a clinical-stage developer of therapies for the treatment of cancer and rare diseases. Prior to Protara, Nicacio served as Senior Vice President, Head of Clinical Development and Global Medical Affairs at Stemline Therapeutics, a subsidiary of the Menarini Group. For comments and feedback contact: [email protected] Business News July 13, 2026 10:12 ET The week saw the release of the minutes of the Federal Reserve’s latest monetary policy session, foreign trade figures and survey data on manufacturing and services in the U.S. External trade data from Germany was the highlight in Europe, while the latest macroeconomic projections from the Asian Development Bank and the International Monetary Fund gained attention.